Obsessive-compulsive symptom clusters and urinary amine correlates in tourette syndrome

Journal of Nervous and Mental Disease

Volumn 183, Issue 4, 1995, Pages 224-230

  De Groot, Christopher M ^a   Bornstein, Robert A ^a   Baker, Glen B ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CATECHOLAMINE; INDOLEAMINE; SEROTONIN;

ADOLESCENT; ARTICLE; COMPULSION; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSION; SCHOOL CHILD; URINE;

ADOLESCENT; BIOGENIC AMINES; CHILD; DOPAMINE; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMAN; HYDROXYINDOLEACETIC ACID; MALE; METHOXYHYDROXYPHENYLGLYCOL; OBSESSIVE-COMPULSIVE DISORDER; PERSONALITY INVENTORY; PHENETHYLAMINES; SEROTONIN; SEVERITY OF ILLNESS INDEX; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TOURETTE SYNDROME;

EID: 0028947597     PISSN: 00223018     EISSN: 1539736X     Source Type: Journal    
DOI: 10.1097/00005053-199504000-00007     Document Type: Article

References (45)

1. Ang L, Borison R, Dysken M, Davis JM (1982) Reduced excretion of MHPG in Tourette syndrome. In AJ Friedhoff, TN Chase (Eds), Advances in neurology (Vol 35, pp. 171-175). New York: Raven.
2. Baer L (1994) Factor analysis of symptom subtypes of obsessive-compulsive disorder and their relation to personality and tic disorders. J Clin Psychiatry 55(Suppl 3): 18-23.
3. Baker GB, Bornstein RA, Douglass AB, Carroll A, King G (1991) Urinary excretion of metabolites of norepinephrine in Tourette's syndrome. Mol Chem Neuropathol 13:225-232.
4. Baker GB, Yeragani VK, Dewhurst WG, Courts RT, MacDonald RN, Wong JTF (1987) Simultaneous analysis of urinary m-and p-hydro-xphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-ace-tic acid using electron-capture gas chromatography. Biochem Arch 3:257-264.
5. Bornstein RA, Baker GB (1989) Urinary amines in Tourette's syndrome patients with and without phenylethylamine abnormality. Psychiatry Res 31:279-286.
6. Bornstein RA, Baker GB (1991a) Neuropsychological performance and urinary phenylethylamine in Tourette's syndrome. J Neuropsychiatry Clin Neurosci 3:417-421.
7. Bornstein RA, Baker GB (1991b) Urinary indoleamines in Tourette syndrome patients with obsessive-compulsive characteristics. Psychiatry Res 41:267-274.
8. Butler IJ, Koslow SH, Seifert WE, Caprioli RM, Singer HS (1979) Biogenic amine metabolism in Tourette's syndrome. Ann Neurol 6:37-39.
9. Cath DC, Hoogduin CAL, van de Wetering BJM, van Woerkom TCAM, Roos RAC, Rooymans, HGM (1992) Tourette syndrome and obsessive-compulsive disorder: An analysis of associated phenomena. In TN Chase, AJ Friedhoff, DJ Cohen (Eds), Advances in neurology (Vol 58, pp. 33-41). New York: Raven.
10. Cattell RB (1966) The scree test for the number of factors. Multivariate Behav Res 1:245-276.
11. Cohen DJ, Leckman JF, Shaywitz BA (1985) The Tourette syndrome and other tics. In D Shaffer, AA Ehrhardt, LL Greenhill (Eds), The clinical guide to child psychiatry (pp. 3-28). New York: Free Press.
12. Cohen DJ, Shaywitz BA, Caparulo B, Young JG, Bowers MB (1978) Chronic, multiple tics of Grilles de la Tourette's disease: CSF acid monoamine metabolites after probenecid administration. Arch Gen Psychiatry 35:245-250.
13. Cohen DJ, Shaywitz BA, Young JG (1979) Central biogenic amine metabolism in children with the syndrome of chronic multiple tics of Gilles de la Tourette. J Am Acad Child Psychiatry 18:320-241.
14. Comings DE, Comings BG (1987) A controlled study of Tourette syndrome. IV. Obsessions, compulsions and schizoid behavior. Am J Hum Genet 41:782-803.
15. Cooper J (1970) The Leyton Obsessional Inventory. Psychol Med 1:48-64.
16. Courts RT, Baker GB, LeGatt DF, Mcintosh GJ, Hopkinson G, Dewhurst WG (1981) Screening for amines of psychiatric interest in urine using gas chromatography with electron-capture detection. Prog Neuropsychopharmacol Biol Psychiatry 5:565-568.
17. Cummings JL, Frankel M (1986) Gilles de la Tourette syndrome and the neurological basis of obsessions and compulsions. Biol Psychiatry 20:1117-1126.
18. Frankel M, Cummings JL, Robertson MM, Trimble MR, Hill MA, Benson DF (1986) Obsessions and compulsions in Gilles de la Tourette's syndrome. Neurology 36:378-382.
19. George MS, Trimble MR, Ring HA, Sallee FR, Robertson MM (1993) Obsessions in obsessive-compulsive disorder with and without Gilles de la Tourette's syndrome. Am J Psychiatry 150:93-97.
20. Goetz CG, Tanner CM, Wilson RS, Carroll VS, Como PG, Shannon KM (1987) Clonidine and Gilles de la Tourette syndrome: Double-blind study using objective rating methods. Ann Neurol 21:307-310.
21. Gottfries CG, Gottfries I, Johansson B, Olsson R, Persson T, Roos B-E, Sjostrom R (1971) Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex. Neuropharmacology 10:665-672.
22. Green RC, Pitman RK (1986) Tourette syndrome and obsessive-compulsive disorder. In MA Jenike, L Baker, WR Minichiello (Eds), Obsessive-compulsive disorders: Therapy and management (pp. 147-164). Littleton, MA: PSG.
23. Holzer JC, Goodman WK, McDougle CJ, Pauls DL (1994) Obsessive-compulsive disorder with and without a chronic tic disorder: A comparison of symptoms in 70 patients. Br J Psychiatry 164:469-473.
24. Keshavan MS, Mazzara C, Brar J, Dequardo JF (1991) Positive and negative symptoms and neuroendocrine dysfunction in schizophrenia. In JF Greden, R Tandon (Eds), Negative schizophrenic symptoms: Pathophysiology and clinical implications (Progress in Psychiatry Series No. 28). Washington, DC: American Psychiatric Press.
25. Kurlan R, Como PG, Deeley C, McDermott M, McDermott MP (1993) A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette's syndrome. Clin Neurophar-macol 16(2):167-172.
26. Leckman JF, Anderson GM, Cohen DJ, Ort S, Harcherik DF, Hoder EL, Shaywitz BA (1984) Whole blood serotonin and tryptophan levels in Tourette's disorder: Effects of acute and chronic clonidine Life Sci 35:2497-2503.
27. Leckman JF, Ort S, Caruso KA, Anderson GM, Riddle MA, Cohen DJ (1986) Rebound phenomena in Tourette's syndrome after abrupt withdrawal of clonidine. Behavioral, cardiovascular, and neuro-chemical effects. Arch Gen Psychiatry 43:1186-1175.
28. Leckman JF, Riddle MA, Cohen DJ (1988) Pathobiology of Tourette's syndrome. In DJ Cohen, RD Bruun, JF Leckman (Eds), Tourette's syndrome and tic disorder (pp. 104-116). New York: Raven.
29. Maas JW, Hattox SE, Green NM, Landis DH (1979) 3-Methoxy-4-hydroxyphenylethyleneglycol production by human brain in vivo. Science 205:1025-1027.
30. Markianos E, Beckmann H (1976) Diurnal changes in dopamine p hydroxylase, homovanillic acid, and 3-methoxy-4-hydroxy-phenyl-glycol in serum of man. J Neural Transm 39:79-93.
31. Montgomery MA, Clayton PJ, Friedhoff AJ (1982) Psychiatric illness in Tourette syndrome patients and first-degree relatives. In TN Chase, AJ Friedhoff (Eds), Gilles de la Tourette syndrome (pp. 335-339). New York: Raven.
32. Nee LE, Caine EE, Polinsky RJ, Eldridge R, Ebert MH (1980) Gilles de la Tourette syndrome: Clinical and family study of 50 cases. Neurology 7:41-49.
33. Olson SC, Nasrallah HA, Coffman JA, Schwarzkopf SB (1991) CT and MRI abnormalities in schizophrenia: Relationship with negative symptoms. In JF Greden, R Tandon (Eds), Negative schizophrenic symptoms: Pathophysiology and clinical implications (Progress in Psychiatry Series No. 28). Washington, DC: American Psychiatric Press.
34. Pauls DL, Towbin KE, Leckman JF, Zahner GEP, Cohen DJ (1986) Gilles de la Tourette's syndrome and obsessive compulsive disorder: Evidence supporting a genetic relationship. Arch Gen Psychiatry 43:1180-1182.
35. Pitman RK, Green RC, Jenike MA, Mesulam MM (1987) Clinical comparison of Tourette's disorder and obsessive-compulsive disorder. Am J Psychiatry 144:1166-1171.
36. Riddle MA, Hardin RN, King R, Scalhill L, Woolston MD (1990) Fluoxetine treatment of children and adolescents with Tourette's and obsessive-compulsive disorders: Preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 29(l):45-48.
37. Riddle MA, Leckman JF, Anderson GM, Ort SI, Hardin MT, Stevenson J, Cohen DJ (1988) Plasma MHPG: Within-and across-day stability in children and adults with Tourette's syndrome. Biol Psychiatry 24:391-398.
38. Ross MS, Moldofsky H (1978) A comparison of pimozide and haloperi-dol in the treatment of Gilles de la Tourette's syndrome. Am J Psychiatry 135:585-587.
39. Shapiro AK, Shapiro E (1983) Controlled study of pimozide vs pla-cebo in Tourette's syndrome. J Am Acad Child Psychiatry 23:161-173.
40. Singer HS, Butler LJ, Tune LE, Seifert WE, Coyle JT (1982) Dopaminergic dysfunction in Tourette syndrome. Ann Neurol 12:361-366.
41. Singer HS, Pepple JM, Ramage AL, Butler IJ (1978) Gilles de la Tourette syndrome: Further studies and thoughts. Ann Neurol 4:21-25.
42. Singer HS, Walkup JT (1991) Tourette syndrome and other tic disorders; Diagnosis, pathophysiology, and treatment. Medicine 70:15-32.
43. Swedo SE, Rapoport JL, Leonard HL, Lenane M, Cheslow D (1989) Obsessive-compulsive disorder in children and adolescents: Clinical phenomenology of 70 consecutive cases. Arch Gen Psychiatry 46:335-341
44. Wong JTF, Baker GB, Coutts RT (1988) Rapid and simple procedure for the determination of urinary phenylacetic acid using derivatiza-tion in aqueous medium followed by electron-capture gas chromatography. J Chromatography B Biomed Appl 428:140-146.
45. Zwick R, Velicer WF (1986) Comparison of five rules for determining the number of components to retain. Psychol Bull 99:432-442.